Perrigo Company plc Operating Lease, Weighted Average Discount Rate, Percent
Perrigo Company plc (PRGO) had Operating Lease, Weighted Average Discount Rate, Percent of 4.00% as of 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-08-05
- 2026-06-27: Operating Lease, Weighted Average Discount Rate, Percent 4.00%.
- 2026-03-28: Operating Lease, Weighted Average Discount Rate, Percent 4.00%.
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 4.00%.
- 2025-09-27: Operating Lease, Weighted Average Discount Rate, Percent 4.00%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent | Operating Lease, Weighted Average Discount Rate, Percent as first filed |
|---|---|---|
| 2026-06-27 | 4.00% 10-Q · filed 2026-08-05 | |
| 2026-03-28 | 4.00% 10-Q · filed 2026-05-06 | |
| 2025-12-31 | 4.00% 10-K · filed 2026-02-26 | |
| 2025-09-27 | 4.00% 10-Q · filed 2025-11-05 | |
| 2025-06-28 | 4.00% 10-Q · filed 2026-08-05 | |
| 2025-03-29 | 3.90% 10-Q · filed 2026-05-06 | |
| 2024-12-31 | 3.88% 10-K · filed 2026-02-26 | |
| 2024-09-28 | 3.80% 10-Q · filed 2025-11-05 | |
| 2024-06-29 | 3.60% 10-Q · filed 2025-08-06 | |
| 2024-03-30 | 3.30% 10-Q · filed 2025-05-07 | |
| 2023-12-31 | 3.17% 10-K · filed 2025-02-28 | |
| 2023-09-30 | 2.70% 10-Q · filed 2024-11-06 | |
| 2023-07-01 | 2.60% 10-Q · filed 2024-08-02 | |
| 2023-04-01 | 2.50% 10-Q · filed 2024-05-07 | |
| 2022-12-31 | 2.48% 10-K · filed 2024-02-27 | |
| 2022-10-01 | 2.50% 10-Q · filed 2023-11-07 | 2.53% 10-Q · filed 2022-11-08 |
| 2022-07-02 | 2.50% 10-Q · filed 2023-08-08 | 2.53% 10-Q · filed 2022-08-09 |
| 2022-04-02 | 2.60% 10-Q · filed 2023-05-09 | 2.61% 10-Q · filed 2022-05-11 |
| 2021-12-31 | 2.63% 10-K · filed 2023-02-28 | |
| 2021-10-02 | 2.60% 10-Q · filed 2022-11-08 | |
| 2021-07-03 | 2.71% 10-Q · filed 2022-08-09 | |
| 2021-04-03 | 2.97% 10-Q · filed 2022-05-11 | |
| 2020-12-31 | 3.02% 10-K · filed 2022-03-01 | 3.24% 10-K · filed 2021-03-01 |
| 2020-09-26 | 3.64% 10-Q · filed 2021-11-12 | 3.80% 10-Q · filed 2020-11-05 |
| 2020-06-27 | 3.73% 10-Q · filed 2021-08-11 | 3.87% 10-Q · filed 2020-08-05 |
| 2020-03-28 | 3.97% 10-Q · filed 2021-05-12 | 4.06% 10-Q · filed 2020-05-05 |
| 2019-12-31 | 4.11% 10-K · filed 2021-03-01 | |
| 2019-09-28 | 4.17% 10-Q · filed 2020-11-05 | |
| 2019-06-29 | 4.19% 10-Q · filed 2020-08-05 | |
| 2019-03-30 | 4.20% 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |